Incidence, disease course, therapeutic strategies and outcomes of inflammatory bowel disease-unclassified patients in Western Hungary: A population-based cohort.
Fruzsina Balogh, Lorant Gonczi, Dorottya Angyal, Petra Anna Golovics, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Akos Ilias, Laszlo Lakatos, Peter Laszlo Lakatos
{"title":"Incidence, disease course, therapeutic strategies and outcomes of inflammatory bowel disease-unclassified patients in Western Hungary: A population-based cohort.","authors":"Fruzsina Balogh, Lorant Gonczi, Dorottya Angyal, Petra Anna Golovics, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Akos Ilias, Laszlo Lakatos, Peter Laszlo Lakatos","doi":"10.3748/wjg.v31.i33.109800","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The number of population-based studies on unclassified inflammatory bowel disease (IBD-U) is very limited.</p><p><strong>Aim: </strong>To evaluate the long-term incidence, disease course and surgery rates of IBD-U in a prospective population-based cohort.</p><p><strong>Methods: </strong>The present study is a continuation of the well-established Veszprem IBD cohort with patient inclusion between 1977 and 2018. Both in-hospital and outpatient records were collected. The source of age- and gender-specific demographic data was derived from the Hungarian Central Statistical Office. Medical therapy, surgery and change in disease phenotype were analyzed.</p><p><strong>Results: </strong>Data of 119 incident IBD-U patients were analyzed [male/female: 55/64; median age at diagnosis: 34 years (interquartile range: 24-47.5)]. Adjusted mean incidence rate was 0.76 (95%CI: 0.63-0.9)/10<sup>5</sup> person-years in the total study period. Disease extent at diagnosis was extensive (pancolitis) in 56.3%. Twenty-two of 119 (18.5%) patients were reclassified to Crohn's disease during follow up, the probability of developing terminal ileum involvement was 6.8%, while perianal disease developed in 5% (<i>n</i> = 6). The probability of receiving biological therapy in patients diagnosed after the year 2000 (<i>n</i> = 62), was 15.5% (SD: 4.8) at 5 years. The overall resective surgery rate was 16.8%. Segment resection was performed in 5.0% of the patients, and 11.8% underwent subtotal or total colectomy. The cumulative probability of resective surgery was 7.6% (SD: 2.4) at 1 year, 9.3% (SD: 2.7) at 5 years, 13.5% (SD: 3.3) at 10 years, and 18.5% (SD: 3.9) at 20 years.</p><p><strong>Conclusion: </strong>These data extend our knowledge on the overall burden of IBD-U. Colonic involvement was extensive in a high proportion of IBD-U. Disease reclassification to Crohn's disease was relatively high. High rates of biological therapy and surgery rates support a relatively severe disease course of IBD-U.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"31 33","pages":"109800"},"PeriodicalIF":5.4000,"publicationDate":"2025-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12417946/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3748/wjg.v31.i33.109800","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The number of population-based studies on unclassified inflammatory bowel disease (IBD-U) is very limited.
Aim: To evaluate the long-term incidence, disease course and surgery rates of IBD-U in a prospective population-based cohort.
Methods: The present study is a continuation of the well-established Veszprem IBD cohort with patient inclusion between 1977 and 2018. Both in-hospital and outpatient records were collected. The source of age- and gender-specific demographic data was derived from the Hungarian Central Statistical Office. Medical therapy, surgery and change in disease phenotype were analyzed.
Results: Data of 119 incident IBD-U patients were analyzed [male/female: 55/64; median age at diagnosis: 34 years (interquartile range: 24-47.5)]. Adjusted mean incidence rate was 0.76 (95%CI: 0.63-0.9)/105 person-years in the total study period. Disease extent at diagnosis was extensive (pancolitis) in 56.3%. Twenty-two of 119 (18.5%) patients were reclassified to Crohn's disease during follow up, the probability of developing terminal ileum involvement was 6.8%, while perianal disease developed in 5% (n = 6). The probability of receiving biological therapy in patients diagnosed after the year 2000 (n = 62), was 15.5% (SD: 4.8) at 5 years. The overall resective surgery rate was 16.8%. Segment resection was performed in 5.0% of the patients, and 11.8% underwent subtotal or total colectomy. The cumulative probability of resective surgery was 7.6% (SD: 2.4) at 1 year, 9.3% (SD: 2.7) at 5 years, 13.5% (SD: 3.3) at 10 years, and 18.5% (SD: 3.9) at 20 years.
Conclusion: These data extend our knowledge on the overall burden of IBD-U. Colonic involvement was extensive in a high proportion of IBD-U. Disease reclassification to Crohn's disease was relatively high. High rates of biological therapy and surgery rates support a relatively severe disease course of IBD-U.
期刊介绍：
The primary aims of the WJG are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in gastroenterology and hepatology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
